Gold 2025 Copd Guidelines Cdc. Panelists discuss how the boreas and notus phase 3 trials demonstrated that dupilumab significantly reduced exacerbations, improved lung function, and enhanced quality. Powerpoint slide set summarizing gold’s objectives, documents, and management recommendations from the 2024 update of the gold report, with background information.
Powerpoint slide set summarizing gold’s objectives, documents, and management recommendations from the 2024 update of the gold report, with background information. Han, a member of the gold scientific committee tasked with the recent update, then discussed the rationale for inclusion of the 2 new medications, emphasizing how the additions reflect a focus on disease.